Phenylephrine gel - SLA Pharma

Drug Profile

Phenylephrine gel - SLA Pharma

Alternative Names: Incostop; SLV-325; VEN 308

Latest Information Update: 29 Jul 2016

Price : $50 *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator SLA Pharma
  • Developer Assembly Biosciences; SLA Pharma
  • Class Antihypotensives; Decongestants; Ethanolamines; Gene therapies; Mydriatics; Phenethylamines; Skin disorder therapies; Small molecules; Urologics
  • Mechanism of Action Alpha adrenergic receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • No development reported Faecal incontinence

Most Recent Events

  • 29 Jul 2016 Discontinued - Phase-I for Faecal Incontinence in Europe (Rectal)
  • 27 Jul 2016 No recent reports on development identified - Phase-II for Faecal Incontinence in North America (Rectal)
  • 11 Jul 2014 Ventrus Biosciences has merged with Assembly Pharmaceuticals to form Assembly Biosciences
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top